insights_auto
Why is PTGX up 2.62%?
Dive Deeperchevron_right
PTGX:NASDAQ
Protagonist Therapeutics Inc
$143.58
arrow_upward
+2.62%(+3.67) 1D
Oct 9, 11:18:44 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
$139.91
High
$145.20
Low
$138.95
Mkt. cap
9.29B
Avg. vol.
714.90K
Volume
181.41K
P/E ratio
138.44
52-wk high
$160.81
52-wk low
$65.77
EPS
$1.04
Beta
1.53
Shares outstanding
64.71M
No. of employees
141
Open
$139.91
High
$145.20
Low
$138.95
Mkt. cap
9.29B
Avg. vol.
714.90K
Volume
181.41K
P/E ratio
138.44
52-wk high
$160.81
52-wk low
$65.77
EPS
$1.04
Beta
1.53
Shares outstanding
64.71M
No. of employees
141
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 months ago
PTGX Q1 2026 Earnings: Unexpected Profit Delivers 109.2% EPS Surprise as Shares Slip - Earnings Momentum Score
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, California, United States
SectorBiotechnology
Websiteprotagonist-inc.com